魏勇军，博士，郑州大学药学院副教授，博士生导师，河南省中兽药发酵制剂工程技术研究中心主任。获得第十五届河南青年科技奖等。主要研究方向：中草药活性分子的微生物转化和合成。主持国自然面上、国际（地区）合作与交流、青年基金、河南省优青、河南省高校科技创新人才、英国皇家学会中英国际交流等项目。已发表论文100余篇，其中，以第一/通讯作者在Trends in Biotechnology、iMeta 等期刊发表论文70余篇；论文他引3000余次，H因子为30。以第一主编在Elsevier出版合成生物学英文书籍2本，主编/参编其他中英文著作6本。

魏勇军博士担任BMC Microbiology、iMeta、The Innovation 等30余本英文期刊编委、青年编委、客座编辑等。担任Nature Communication 等70余本高水平杂志的审稿人。已获批11项国际专利在内的24项专利，在审专利16项。相关成果获得河南省科技进步奖二等奖等。担任欧洲研究理事会协同类基金项目（1400万欧元/项）评审人等。担任国际应用微生物学会咨询委员会委员、河南省微生物学会理事等。指导国家级大学生创新创业训练项目等本科生科研项目10多项；指导学生获得全国大学生化妆品创新大赛一等奖、国家奖学金等20余项奖励。

联系方式：yongjunwei@zzu.edu.cn

Yongjun Wei, Ph.D, currently work as an Associate Professor at the School of Pharmaceutical Sciences and Laboratory of Synthetic Biology, Zhengzhou University, China. He serves as the director of Henan Province Engineering Technology Research Center for Fermentation of Chinese Veterinary Drugs. His research interest is synthetic microbiology, with a focus on applying microbiota and synthetic biology in addressing human health issues.

To date, he has published more than 100 papers with over 3000 citations (Google Scholar h-index: 30). He currently serves as editorial board member for BMC Microbiology, BMC Biotechnology, and other >30 different journals. He has reviewed numerous articles for over 60 different journals. He holds 24 patents, including 11 international patents. Additionally, he acts as a consultant for several biotechnology companies.